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Background: Epidermal growth factor receptor (EGFR) signalling plays a major role in biological processes, including
cell proliferation, differentiation and survival. Since the over-expression of EGFR causes human cancers, EGFR is an
attractive drug target. A tumor suppressor endogenous protein, MIG-6, is known to suppress EGFR over-expression by
binding to the C-lobe of EGFR kinase. Thus, this C-lobe of the EGFR kinase is a potential new target for EGFR kinase
activity inhibition. In this study, molecular dynamics (MD) simulations and binding free energy calculations were used
to investigate the protein-peptide interactions between EGFR kinase and a 27-residue peptide derived from MIG-6_s1
segment (residues 336–362).
Results: These 27 residues of MIG-6_s1 were modeled from the published MIG-6 X-ray structure. The binding dynamics
were detailed by applying the molecular mechanics Poisson-Boltzmann surface area (MM-PBSA) method to predict the
binding free energy. Both van der Waals interactions and non-polar solvation were favorable driving forces for binding
process. Six residues of EGFR kinase and eight residues of MIG-6_s1 residues were shown to be responsible for interface
binding in which we investigated per residue free energy decomposition and the results from the computational
alanine scanning approach. These residues also had higher hydrogen bond occupancies than other residues at the
binding interface. The results from the aforementioned calculations reasonably agreed with the previous experimental
mutagenesis studies.
Conclusions: Molecular dynamics simulations were used to investigate the interactions of MIG-6_s1 to EGFR kinase
domain. Our study provides an insight into such interactions that is useful in guiding the design of novel anticancer
therapeutics. The information on our modelled peptide interface with EGFR kinase could be a possible candidate for an
EGFR dimerization inhibitor.
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EGFR, also known as ErbB1 or HER, is a receptor tyro-
sine kinase that mediates in biological process of normal
physiology [1]. An over-expression of EGFR has often
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unless otherwise stated.can provide the basic properties required for cancer
growth, including cell proliferation, anti-apoptosis, me-
tastasis and angiogenesis [2]. These properties render
EGFR an attractive target for cancer therapy. Nonethe-
less, several reports show that the secondary mutations
in EGFR cause anticancer drug resistances [3-5], insti-
gating a requirement of efficient treatments to overcome
these resistances. Zhang et al. [6] showed that a new target
therapy could be done by the suppression of EGFR activa-
tion through an allosteric mechanism. This approach was
supported by an association of the endogenous negative-
feedback-inhibitor protein, called MIG-6, that regulatesl. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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the EGFR kinase/MIG-6 complex showed that a segment
of MIG-6 (residues 337–361), called MIG-6_s1 interacts
with the C-lobe of EGFR kinase domain (Figure 1) [6].
The binding of MIG-6_s1 to EGFR kinase prevents an
asymmetric dimer formation, leading to the inhibition of
EGFR activation at micro molar binding affinity level [6].
The detailed analysis of the protein-protein interactions
(PPI) at an atomic level of EGFR kinase and MIG-6_s1 is
yet limited. Molecular dynamics (MD) simulations and
free energy calculation can be used to obtain the know-
ledge on the dynamics of the structures and the binding
energy profiles of the protein complexes in solution [9].
In this study, MD simulations were performed on the
EGFR kinase/MIG-6_s1 complex to obtain the knowledge
on their binding dynamics and structural changes. The
binding free energy calculation by the MM-PBSA method
was applied to gain a better understanding on the binding
energetics of the complex. The per residue free energy de-
composition and alanine scanning methods were used to
elucidate the residues important for interface binding and
to obtain their energetic contributions. Our results pro-
vided a better understanding of the binding interactions
between EGFR kinase and MIG-6_s1 peptide. Moreover,
such information could be used to improve or develop
more efficient anti-cancer drugs.
Methods
Model setup and molecular dynamics simulations
The starting structures of EGFR kinase/MIG-6_s1 and
the asymmetric kinase dimer complexes were based onFigure 1 Cartoon representation of the crystal structure of the EGFR
spanned on the EGFR kinase interface.the X-ray crystal structure from the protein data bank
(PDB). The monomer structures of the EGFR kinase
activators (residues 678–959) and MIG-6_s1 (residues
337–362) were used (PDB code: 2RFE) [6], while PDB
code: 2GS6 represents the EGFR kinase receiver model.
The N- and C-termini of EGFR kinase and MIG-6_s1
were capped with an acetyl group (ACE) and an N-
methyl group (NME), respectively [10]. All simulations
were performed using AMBER 12 and the ff03 force
field [11]. Each system was solvated using the atomistic
TIP3P water model [12] in an octahedron truncated box
with a buffer distance of 7 Å. Hydrogen atoms were
added, and the counter-ions of Na+ or Cl− were used to
neutralize the system. To remove bad contacts in the
crystal structure, we applied three-step minimization to
each system before performing the simulations. Pos-
itional restraints were applied to the whole system in the
first and the second steps with a force constant of
10 kcal/(mol Å2) and 2 kcal/(mol Å2), respectively. In
the third step, all atoms were allowed to move freely
without restraints. The energy minimization in each step
was carried out using 2,000 cycles of the steepest des-
cent algorithm, followed by 300 cycles of the conjugate
gradient algorithm. Each system was heated from 0 to
300K during the 100 ps in an NVT ensemble and was
further equilibrated for 500 ps in an NPT ensemble.
Then it was simulated for 22 ns in an NPT ensemble at
1 atm and 300K, using the 2 fs integration time step.
During the simulations, the particle mesh Ewald (PME)
method [13] was used to treat the long-range electrostat-
ics. Moreover, the SHAKE algorithm [14] was applied tokinase/MIG-6_s1 complex. The positions of MIG-6_s1 residues were
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ing hydrogen, thereby allowing the use of a 2 fs time
step.
Calculation of binding free energy using the MM-PBSA
approach
The MM-PBSA approach [15] was used to calculate
protein-protein binding free energies. 300 snapshots
were extracted from the last 3 ns of the MD trajectories
to perform MM-PBSA. The binding free energy of each
snapshot was calculated as follows:
ΔG bindð Þ ¼ G complexð Þ−G proteinð Þ−G ligandð Þ ð1Þ
The free energy (G) for each molecule can be computed
from the following equations:
G ¼ ΔE gasð Þ−ΔG solð Þ−ΤΔS ð2Þ
ΔE gasð Þ ¼ E intð Þ þ E vdwð Þ þ E eleð Þ ð3Þ
E intð Þ ¼ E bondð Þ þ E angleð Þ þ E torsionð Þ ð4Þ
G solð Þ; PB ¼ G PBð Þ þ G nonpol; solð Þ ð5Þ
G nonpol; solð Þ ¼ γSASA ð6Þ
ΔE (gas) is the gas-phase energy, which is the sum of
the internal (Eint), van der Waals (Evdw) and Coulomb
energies (Eele) (Eq. 3). Internal energy (Eint) comprises
the bond (Ebond), angle (Eangle) and torsion (Etorsion)
energies, respectively (Eq.4). The solvation free energy
(Gsol, PB) comes from the combination of polar (GPB)
and non-polar contributions (Gnonpol, sol) (Eq.5). Note
that G (PB) is the polar solvation calculated by the
Poisson-Boltzmann (PB) equation with the dielectric
constants of 1.0 for solute and 80.0 for solvent. The
non-polar component (Gnonpol, sol) is defined in Eq. 6,
where the constant γ was set to 0.0072 kcal/mol, while
SASA stands for the solvent-accessible-surface area
calculated by the linear combination of pairwise overlap
[16] model. Finally, −TΔS in Eq. 2 is an entropy term
calculated from the sum of translational, rotational and
vibrational components using normal mode analysis. To
gain more insights into the residue contributions, the
residues of MIG-6_s1 responsible for the binding to the
EGFR kinase surface were computed by using the MM-
PBSA per residue free energy decomposition method
(mm_pbsa module) of AMBER12. These calculations
were based on the same snapshots as those used in the
binding free energy calculations.
Computational alanine scanning mutagenesis
To investigate the contributions of an individual residue
to the binding interface and to identify the “hot-spot”
residues that are very important for interface binding,we used computational alanine scanning to identify
these key residues of the EGFR kinase/MIG-6_s1 inter-
face as well as the asymmetric dimer interface. Alanine
scanning replaces an original residue with alanine; this
substitution eliminates the side-chain but does not intro-
duce large conformational changes to alter the mode of
binding [17]. The binding free energy of the wild type
and mutant were calculated using a post-processing
treatment of the mm_pbsa module and the difference in
their binding free energies was computed using the
following equation [10,18]:
ΔΔGbinding ¼ ΔGbinding of wildtype−ΔGbinding of mutant
ð7Þ
Based on the post-processing energy calculation
[19,20], the alanine mutant structure was generated by
eliminating the residue side-chain with a hydrogen atom
of alanine prior to the calculation. Note that the smallest
amino acid, glycine, was not included since it introduces
conformational flexibility into the protein backbone.
Proline was also not included because its backbone con-
formation differs from that of alanine [21-23]. The 300
snapshots extracted from the last 3 ns of the MD runs
were used in these calculations. If the difference in bind-
ing free energy between the wild type and the mutant of
a residue (ΔΔGbinding) becomes positive, such an alanine
substitution is favorable, i.e., this residue is probably not
important in the interface binding. However, the nega-
tive value of ΔΔGbinding indicates the unfavorable
alanine substitution, i.e., this residue plays significant
role in the interface binding [18]. These key residues
were clarified as the residues that significantly de-
crease the binding free energy for at least 2.0 kcal/
mol. From literatures, residues with strong binding
should reduce the binding free energy greater than or
equal to 4 kcal/mol [21,24].
Results and discussion
Structural stabilities and flexibilities of the systems
To assess the dynamic stabilities of the systems, we per-
formed MD simulations of EGFR kinase and MIG-6_s1
in both unbound and bound states with explicit water
for 22 ns at 300K under 1 atm pressure. The equilibra-
tion of MD simulations can be observed from the con-
vergence of the root-mean-square deviation (RMSD)
plot, based on the backbone (Cα, N and O) atoms of
each snapshot as compared to the initial energy mini-
mized structure.
The RMSD plots of three systems: 1) unbound EGFR
kinase 2) unbound MIG-6_s1 and 3) EGFR kinase/MIG-
6_s1 complex are shown in Figure 2. For the bound
system, beside the plot for overall complex (black line),
we also plotted the RMSD values for only EGFR kinase
Figure 2 The Root-Mean-Square Deviation (RMSD) plots of the EGFR kinase /MIG-6_s1 backbones in the bound and unbound states of
the 22-ns simulation. RMSD plots of unbound EGFR kinase and unbound MIG-6_s1 are shown in purple and yellow lines, respectively. For the
complex of EGFR kinase/MIG-6_s1, three RMSD plots are presented. The black line represents the RMSD of the entire complex of EGFR kinase/
MIG-6_s1. The RMSD plot for only EGFR kinase in the complex is shown in red. The RMSD plot for only MIG-6_s1 in the complex is shown in green.
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plots of “unbound EGFR kinase”, “EGFR kinase/MIG-6_s1
complex” and “only EGFR kinase in complex” reached
their plateaus after about 2 ns. The RMSD plots of only
MIG-6_s1 in the EGFR complex reached its plateau after
about 7 ns. These three systems were equilibrated during
the 22 ns simulations.
The conformational changes in the bound and
unbound simulations were compared (Figure 2). Both
bound and unbound EGFR kinase RMSD plots revealed
similar patterns with average RMSD value of ~3.0 Å for
unbound EGFR and ~2.9 Å for bound. For bound vs.
unbound MIG-6_s1, the RMSD plot of bound MIG-6_s1
is more stable than that of unbound state with average
RMSD of ~4.2 Å for bound MIG-6_s1 and ~6.4 Å for
the unbound MIG-6_s1. It can be seen that the bound
MIG-6_s1 was significantly more stable than the un-
bound state as seen in the lower RMSD fluctuation.
Note that the unbound MIG-6_s1 has generally higher
RMSD values because MIG-6_s1 is rather short peptide
(27 amino acids) and becomes very flexible in solution.
This flexible short peptide phenomenon were also pre-
sented in [17,25] where the unbound short peptide p53
could not be stabilized in solution but could be bound
stably to the binding cleft of MDM2 protein. Thus, from
the RMSD results, our MD simulations are reliable
enough for further investigation.
The root-mean-square fluctuations (RMSF) of αC atom
from the MD simulated structures against the starting
structure were calculated to identify the most flexible re-
gions of the protein-peptide structure. The larger RMSF
value conveys more flexible region while the lower RMSF
value entails the more constrained region.The comparison of both unbound EGFR system and
EGFR kinase/MIG-6_s1 complex system based on their
RMSF profiles (Figure 3A). The RMSF profile of unbound
EGFR kinase system (green) showed similar behavior to
that of EGFR complex system (red). On the contrary, the
RMSF profile of MIG-6_s1 in the unbound state showed
much higher fluctuation than that of its complex state.
When comparing the RMSF EGFR kinase profile with the
dimer complex profile (purple), we observed distinguish-
able patterns in several regions of the EGFR interface to
MIG-6_s1. Within the EGFR N-lobe region, similar RMSF
profiles from all three systems were observed; however the
corresponding RMSF profiles were lower than the other
regions reflecting lower flexibility.
RMSF patterns and their values in the EGFR C-lobe re-
gion differ greatly from that of N-lobe region. Particularly,
residues from both EGFR kinase/MIG-6_s1 complex and
unbound EGFR kinase, especially in the junction αD–αE,
and along the three αG, αH and αI helices revealed high
RMSF values (reaching 5–6 Ǻ); while the EGFR kinase in
dimer complex shows stable RMSF value ~3 Ǻ. We
hypothesize that during EGFR dimerization these helices
must interact with the juxtamembrane B portion of the
EGFR receiver; hence losing the dimerization causes the
EGFR activator to have higher RMSF (see unbound EGFR
kinase). Furthermore, we observed uncertain fluctuations
in the part of Ala840–Gly850, called A-loop, which corre-
lates with the missing residues in the EGFR X-ray crystal
structure (Figure 3B) [26].
Toward to the end of the RMSF plots, the magnitude of
unbound MIG-6 plot (green) differed greatly from that of
complex of EGFR/MIG-6_s1 plot (red). In particular the
RMSF of MIG-6_s1 in EGFR complex (red) was about
Figure 3 Graphical representation of root mean square fluctuation (RMSF) and superimposition of EGFR kinase. (A) The RMSF profiles of
EGFR kinase bound MIG-6_s1 (in red), the unbound of EGFR kinase and MIG-6_s1 (in green), and EGFR kinase in the dimeric structure (in purple)
with EGFR kinase (PDB: 2GS6). Most flexible regions can be seen as peaks in rectangles. (B) the superimposition of EGFR kinase monomers from
1) the unbound EGFR kinase (purple) 2) the EGFR kinase in the binding of MIG-6_s1 complex (orange) and 3) the dimer complex (green). The
superimposition revealed the different mobility of the activation loop (A-loop).
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swung much higher. These evidences suggest that the
binding of EGFR kinase could help MIG-6_s1 structure
to stabilize in complex.
The conformational changes of the EGFR kinase/MIG-6_s1
complex
Twenty-seven residues of MIG-6_s1 (residue 336–362)
can bind to the distal surface of the C-lobe in the EGFR
kinase domain to prevent the activation of EGFR kinase
by asymmetric dimer (Figure 1). To gain a better under-
standing on the structural differences between the initial
structure and the average simulated structure, theFigure 4 The superimposition of the average structure from the last 3
(green) of the EGFR kinase /MIG-6_s1 complex. The positions of Asn343
ball-and-stick representation.superimposition of the minimized initial structure of the
EGFR kinase/MIG-6_s1 complex and its average struc-
ture from the 300 snapshots of the last 3-ns simulations
are shown in Figure 4. The conformations of the average
structure and the minimized initial structure were
mostly similar, except for the shift in the loop region of
MIG-6_s1. Specifically, Asn343 of MIG-6_s1 at the loop
region of the average structure shifted its side-chain up
closer to the EGFR kinase surface region than that of
the minimized initial structure (Figure 4). This contact
was not observed previously in the initial structure pos-
sibly due to crystal packing contacts in the flexible loop
segment [27].ns of simulations (light-pink) and its minimized initial structure
, Met346 and the cluster of prolines of MIG-6_s1 are shown in the
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pocket of the EGFR kinase interface consists of Leu343,
Trp881, Thr885 and Pro913, and the side-chain of
Met346 of MIG-6_s1 resided stably in this pocket, as
shown in Figure 5 (plotted by LIGPLOT program [28]).
Since prolines can affect the rigidity of peptide struc-
tures, the conformations of prolines were also analyzed
in this study. Five prolines of MIG-6_s1 (Pro347,
Pro348, Pro354, Pro356 and Pro339) were in cis-configu-
rations and located on the turn. Four of these residues
(Pro347, Pro348, Pro354 and Pro356) remained in bent
conformation at the interface (Figure 6) [6]. Prolines on
the turn might also form interactions between the proline
ring and nearby aromatic residues (CH-π) [29] and help
stabilize the MIG-6_s1 complex. Similar to prolines in the
SH3 domain, the positions of two prolines were relatively
fixed to constrain the structural movements [30].
The calculations of binding free energies
To compute the binding free energies of MIG-6_s1
peptides to EGFR kinase and to gain insights into the
peptide-protein binding interactions, the MM-PBSA
approach was applied to the 300 snapshots taken from
the last 3 ns of the production runs. The calculated results
are presented in Table 1. The predicted binding free en-
ergy of EGFR kinase/MIG-6_s1 complex was-142.7 kcal/
mol. The major favorable components of the MIG-6_s1
binding were the van der Waals term in gas-phaseFigure 5 The interactions of Met346 with its nearby residues in the a
ball-and-stick representation and its neighbours are shown in brown. Carbo
respectively. Dark red “eyelashes” represent hydrophobic contacts between
involved in hydrophobic contacts.(ΔEvdw =-120.8 kcal/mol) and the non-polar part of the
solvation free energy term (ΔGnonpol, sol =-84.25 kcal/
mol). These two terms resulted in the total favorable
non-polar interactions of-205.1 kcal/mol. The highly
favorable non-polar part of the free energy might come
from the hydrophobic interactions between MIG-6_s1
and EGFR kinase as well as the desolvation of the non-
polar groups of MIG-6_s1 from water that aligned them
with the binding interface [10]. Such a phenomenon could
be seen in several protein-protein interactions including
the interaction between MDM2 and p53, where van der
Waals interaction was the major contributor to the
inhibitor binding originated from the effects of solute-
solvent attractive forces on hydrophobic and the dis-
persion [10,31].
On the other hand, the favorable columbic term in gas
phase (ΔEele =-130.4 kcal/mol) was completely cancelled
by the unfavorable contribution of the polar part of the
solvation free energy (GPB = 151.6 kcal/mol), resulting in
the total unfavorable electrostatic interactions of
21.2 kcal/mol. This compensation phenomenon was dis-
cussed in several studies of protein-protein interactions
in solution, including the binding processes of IGF-II/
IGF2R and hGH/GHR, giving the polar interactions
(ΔEele +GPB) of 31.57 and 134.2 kcal/mol, respectively
[10,32]. Moreover, the magnitude of TΔS is in the range
of +30 to-40 kcal/mol, being consistent with the previ-
ous results [32].verage structure (plotted by LIGPLOT). Met346 is shown in the
n, nitrogen and oxygen atom are shown in black, blue and red,
Met346 and its neighbours. Black eyelashes correspond to atoms
Figure 6 The superimpositions of the average structures during the 1–3 ns (yellow), 10–12 ns (purple), 14–16 ns (pink), and 20–22 ns
(orange) simulations showed the stabilities of prolines over the course of simulations. The positions of prolines on MIG-6_s1 are indicated
on the ball-and-stick representation of EGFR kinase.
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The technique of per-residue binding free energy de-
composition can reveal the contributions of the key resi-
dues responsible for the protein-protein interactions at
the interface. The total of 300 snapshots extracted from
the last 3 ns of the MD trajectories were decomposed by
the MM-PBSA method. The important binding residues
of the EGFR kinase/MIG-6_s1 interface were extracted
using the residue cut-off at ΔGtot,PB ≤-1.0 kcal/mol (favor-
able binding) (Figure 7). There were13 important binding
residues from MIG-6_s1 and 9 residues from EGFR kinase
with binding free energies less than-1 kcal/mol (Figure 8).
The 13 residues of MIG-6_s1 comprise Ser337, Leu338,
Pro339, Tyr341, Met346, Pro348, Thr349, Gln350,
Phe352, Lys357, Tyr358, Val359 and Ser361 whereas the 9
residues of EGFR kinase were Thr885, Glu904, Gly906,Table 1 The binding free energy of the EGFR kinase/MIG-6_s1
PBSA method
Contribution EGFR kinase/MIG-6_s1 EGFR kinas
Mean σ Mean
Eele -21099.37 5.29 -19392.37
EvdW -2536.90 1.24 -2296.92
Egas -23636.27 5.35 -21689.29
Gsol, np 2470.43 0.53 2273.28
Gsol, PB -3449.41 4.13 -3449.41
Gsol -978.98 4.03 -975.73
ΔGcal
-TΔS -233583.65 1.09 -3282.65
ΔGcal - (-TΔS)
Mean energies are in kcal/mol, with the corresponding standard errors (σ).
Eele and Evdw are electrostatic and van der Waals contributions in gas phase.
GPB and Gnp are electrostatic and nonpolar contributions in solvation phase.
ΔGcal is total binding free energy.Arg908, Pro910, Gln911, Pro913, Met928 and Ile929.
Some of these residues, such as Pro910, Thr349, Gln350
and Tyr358, had the values of the binding free energies
less than or equal to -4 kcal/mol. Five residues of MIG-
6_s1, namely Leu342, Asn343, Ser351, Asp355, and
Ser360 and seven residues of EGFR kinase, namely
Glu907, Leu909, Pro912, Tyr920, Val924, Trp927 and
Gly959, had their binding free energies approximately
-1.0 kcal/mol. We further analyzed the binding free energy
component of each residue based on the van der Waals
energy and the sum of electrostatic contribution in the
gas-phase and the polar part of the solvation energy
(Figure 8). The results suggested that the main favorable
contribution to the binding free energy was essentially the
van der Waals interactions. Normally, the favorable elec-
trostatic energies are opposed by the unfavorable polarcomplex and its components calculate using the MM-
e MIG-6_s1 Delta
σ Mean σ Mean σ
4.9 -1576.62 1.48 -130.38 1.03
1.2 -119.22 0.33 -120.75 0.31
4.96 -1695.84 1.59 -251.13 1.01
0.48 281.40 0.21 -84.25 0.16
3.87 -351.98 1.08 151.59 0.93
3.8 -70.58 0.94 67.34 0.93
-183.79 0.5
3.36 -342.04 4.02 41.05 2.08
-142.74 -
Figure 7 The per residue free energy decomposition of EGFR kinase and MIG-6_s1.
Figure 8 Per residue free energy decomposition of the residues at the interface of the EGFR kinase and MIG-6_s1 complex. The van der
Waals energy (red line), the sum of the coulombic interactions and the polar part of the solvation free energy (light blue) and the total binding free
energy (black dot) for key residues with the values≤− 1.0 kcal/mol. All values were given in kcal/mol. Gray line represented the cut off of-1.0 kcal/mol.
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polar groups), resulting in unfavorable contributions.
However, some residues had slightly favorable electrostatic
contributions (the sum of the electrostatic energies and
the polar parts of the solvation free energies) including
Thr885, Glu904, Pro910, Gln911, Pro912 and Trp927 of
EGFR kinase as well as Ser337, Leu338, Ser340, Tyr341,
Val345, Thr349, Pro354, Asp355, Lys357, Val359 and
Ser361 of MIG-6_s1.
Table 2 shows the information on hydrogen bonds
between MIG-6_s1 peptide and EGFR kinase during the
last 3 ns of the simulations. These are the hydrogen
bonds formed between residues Ser337, Tyr341, Asn350,
Phe352, Lys357, Tyr358 and Ser360 of MIG-6_s1 and
the residues Glu904, Gly906, Arg908, Gln911 and Ile929
of EGFR kinase. Strong, medium and weak hydrogen-
bond interactions were defined as having simulated
hydrogen bond occupancy of > 75%, 50–75%, and < 50%,
respectively. The hydrogen bond distance profiles of
some of the strong hydrogen bond interactions during
the 22 ns of the simulations are shown in Figure 9. Most
of these hydrogen bonds were stable throughout the
entire simulations (Figures 9A, B, C, D, E, F, and G),
except for hydrogen bonds shown in Figures 9B, I and
J. In particular, the hydrogen bond between Tyr341-OH
and Gln911-O was briefly disrupted during 13.5–16 ns
of the simulations (Figure 9B). The hydrogen bonds be-
tween Asn343-ND2-HD21 and Thr885-O (Figure 9I)
and between Asn343-NH and Gly959-O (Figure 9J)
were not stably formed until around 13 ns and 18 ns,
respectively.Table 2 Hydrogen bonds found in the last 3-ns of the
simulation
Donor Acceptor Distance (Å) ± SD Occupancy (%)
Arg908-NH Gln350-O 2.916 (0.12) 99.87
Tyr341-OH Gln911-O 2.838 (0.17) 99.27
Gln350-NH Arg908-O 2.907 (0.13) 99.20
Ile929-NH Lys357-O 2.918 (0.15) 98.53
Asn343-NH Gly959-O 2.994 (0.16) 97.73
Ser360-NH Glu904-O 2.841 (0.12) 96.83
Gln911-NE2-HE21 Ser337-O 2.954 (0.16) 96.10
Arg908-NH2-HH22 Tyr358-O 2.969 (0.16) 92.73
Asn343-ND2-HD21 Thr885-O 3.063 (0.18) 89.57
Phe352-NH Gly906-O 3.077 (0.18) 87.43
Gln911-NH Gln350-OE1 3.034 (0.20) 79.33
Thr349-OG1-HG1 Glu907-OE1 2.697 (0.13) 69.90
Ser361-NH Glu904-O 3.112 (0.20) 69.37
Ile917-NH Ser337-O 3.044 (0.17) 51.27
Thr349-OG1-HG1 Glu907-OE2 2.703 (0.18) 24.33
The distance cut-off was 3.5 Å and angle cut-off was 120°.Computational alanine scanning technique
Computational alanine scanning is a powerful technique
that not only monitors the key residues required for the
interactions between the two protein partners at the
interface but also computes the energetic contribution
to the binding free energy of the individual side-chain
based on each alanine mutation [33]. In order to identify
the key residues from the 29 residues along the binding
interface of the EGFR kinase/MIG-6_s1 complex, we
substituted alanine in amino acids having the free energy
contribution less than or equal to-1.0 kcal/mol in order
to classify them as either “hot spot” or “warm spot” resi-
dues. Note that the higher negative value of ΔΔG of an
alanine point substitution represents the better binding
state of the residue. A residue is classified to be very im-
portant for binding to the protein partner (hot spot)
[21,24,34], if its ΔΔG ≤-4 kcal/mol. To a lesser extent,
the “warm spot” will be classified if-2 kcal/mol ≥ ΔΔG
>-4 kcal/mol. In this analysis, proline and glycine resi-
dues were not included since their backbone conforma-
tions differ from alanine.
The results from the alanine scanning method (Figure 10A
and B) and from the per residue free energy decompos-
ition technique (Figure 8) are largely consistent. As de-
termined by the free energy decomposition technique,
most of the important residues were also classified as
hot spot residues. We showed that there were six “hot spot”
residues on EGFR kinase, namely Glu904, Glu907, Arg908,
Gln911, Met928 and Ile929; and eight “hot spot” residues
on MIG-6_s1, namely Leu338, Try341, Asn343, Met346,
Thr349, Gln350, Phe352 and Try358. For the warm spot
classification four residues, Thr885, Ile94, Tyr920 and
Val924, were on EGFR kinase (Figure 10A) while Leu342,
Val359, and Ser361 were on MIG-6_s1 (Figure 10B). How-
ever, due to the limitation of alanine scanning, Gly906,
Pro910, Pro912, Pro913, Gly959 on EGFR kinase and
Pro339, Pro348 on MIG-6_s1 could not be alanine scanned.
Note that by means of per residue free energy decom-
position, eight residues (Tyr891, Leu909, Trp927, Ser337,
Ser351, Asp355, Lys357 and Ser360) were identified as im-
portant residues and not by the alanine scanning approach.
Such discrepancies may stem from the differences in the
energy cut-offs used in these two methods. Moreover, the
alanine scanning method verified only the contributions
from the side-chains, while the free energy decomposition
analysis considered both the contributions from the
side-chains and the backbones. It may be possible that the
contributions from the backbones of these residues may be
more than those of the side-chains [18]. The common
“key” residues identified by both alanine scanning and the
free energy decomposition methods, such as Val924,
Met346, Phe352 and Try358, are supported by the previ-
ous mutagenesis experiment as the alanine replacements
of these residues abolished the peptide binding [6].
Figure 9 Hydrogen bond distance profiles. (A) Between Gln911-NE2-HE21 and Ser337-O. (B) Between Tyr341-OH and Gln911-O. (C) Between
Gln350-NH and Arg908-O. (D) Between Arg908-NH and Gln350-O. (E) Between Phe352-NH and Gly906-O. (F) Between Arg908-NH2-HH22 and
Tyr358-O. (G) Between Ile929-NH and Lys357-O. (H) Between Ser360-NH and Glu904-O. (I) Between Asn343-ND2-HD21 and Thr885-O. (J) Between
Asn343-NH and Gly959-O.
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Figure 10 Schematic representations of the interaction profiles between the EGFR kinase/MIG-6_s1 interfaces. (A) The key residues of
the EGFR kinase surface. (B) The key residues of MIG-6_s1. (C) Hydrogen bond formation between interfaces presented in the starting structure
and the 3 ns last of simulations. Interfacial hydrogen bonds presented in green line with the occupancies higher than 50% (D). The involving of
hydrogen bond and key residues between two interfaces presented in the starting structure and the last 3 ns of simulations. The “hot spot residues”,
“warm spot”, null spot and not studied residues are shown in red, orange, white and gray respectively. Interfacial hydrogen bonds of the starting
structure and MD structure presented in dark green and blue bars, respectively.
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the EGFR kinase/MIG-6_s1 complex
The common key-residue results from both the per resi-
due binding free energy decomposition and computa-
tional alanine scanning technique predicted the most
important residues at the binding interface that includesix residues of the EGFR kinase and eight residues of the
MIG-6_s1peptide segment (Figure 10A and B). These
residues have their ΔΔG ≤-4 kcal/mol after performing
alanine substitution. Both different and consistent inter-
action profiles between the MD simulations and the
starting structures were observed and presented using
Moonrin et al. BMC Bioinformatics  (2015) 16:103 Page 12 of 16hydrogen bonding network (Figure 10C). The resulting
relationship does not only exhibit their interfacial
residues but also some involvements of bonding in the
important residues (Figure 10D). The MD simulations
mostly reveal stable pattern of hydrogen bonds, with the
exception for the bonding of Ser351 to Glu907. Interest-
ingly, these hydrogen bonds were also involved in the
important residues on the interface. This suggests that
the main contributions to the binding interactions were
from the hydrogen bonds.
Mutagenesis studies of MIG-6_s1 revealed the import-
ance of Met346, Phe352 and Tyr358 for EGFR kinase
binding [6]. With the free energy contribution of
approximately-2.8 kcal/mol, Met346 is probably the
most important residue of MIG-6_s1 that contributes to
the hydrophobic interactions at the interface of the
EGFR kinase/MIG-6_s1 complex. The side-chain of
Met346 was buried in the hydrophobic pocket consisting
of Leu343, Trp881, Thr885 (warm spot) and Pro913 of
the EGFR kinase (Figures 4 and 5). The mutating
Met346 to Ala346 costs approximately-8.1 kcal/mol of
the magnitude of the binding free energy, supporting the
importance of its side-chain that engages in the pocket
of EGFR kinase. These results were consistent with the
crystal structure showing Met346 buried in the hydro-
phobic pocket of the EGFR kinase, and the experimental
results that the mutation of Met346 could abolish EGFR
binding [6]. Phe352 and Tyr358 of MIG-6_s1 were also
identified in this study as the essential residues for the
interface binding with the energetic contributions of
about-3.4 and-6.2 kcal/mol, respectively. Their back-
bones formed hydrogen bonds with hot spot residues,
Gly906 and Arg908 (hot spot), respectively, and their
side-chains were also buried in the hydrophobic cleft
(Figure 11A, B and C). Moreover, the phenyl ring of
Phe352 and the phenol ring of Tyr358 formed the paral-
leled π-π interaction with the distance of 5.0 Ǻ between
two centroids (<12.0 Ǻ) (Figure 11C) [29]. Therefore,
the mutations of Phe352Ala and Try358Ala could result
in the loss of van der Waals contributions from the
hydrophobic interactions of their side-chains [6].
Electrostatic and hydrogen bond interactions were also
crucial factors for the binding of MIG-6_s1 and EGFR kin-
ase. Tyr341 of MIG-6_s1 was an important residue for the
binding of MIG-6_s1 and EGFR kinase with per residue
contribution of-1.88 kcal/mol. During the simulations,
Tyr341 formed a hydrogen bond with Gln911 (hot spot)
and was also buried in the hydrophobic pocket of Pro339,
Pro347, Pro910 and Pro913 (Figure 11D). Moreover, the
value of ΔΔG of the alanine substitution of Tyr341 is
about-7.9 kcal/mol, which was influenced by the loss of
van der Waals and electrostatic interactions. Another resi-
due important for the binding of this complex is Thr349
of MIG-6_s1. Thr349 formed a hydrogen bond withGlu907 (hot spot) of EGFR kinase (Figure 11E). The value
of ΔΔG of the alanine substitution of Thr349 is about-
7.4 kcal/mol, caused mainly by the loss of electrostatic
contributions. Moreover, the backbone of Gln350 formed
two hydrogen bonds with the backbone of Arg908 (hot
spot), while its side-chain formed not only a hydrogen
bond with Gln911 (hot spot) but also formed van der
Waals interactions with Pro910 and Try920 (warm spot)
(Figure 11F). The value of ΔΔG of the alanine substitution
of Gln350 is about-4.3 kcal/mol, where van der Waals and
electrostatic contributions were lost upon the side-chain
mutation.
During the simulations, not only the new hydrogen
bond between Ser361 and Glu904 was formed, but the
hydrogen bond involving Asn343 at the loop region of
MIG-6_s1 was also observed. The side-chain of MIG-
6_s1 moved toward the EGFR kinase surface and formed
two hydrogen bonds with Thr885 (warm spot) and
Gly959 (Figure 11G). These hydrogen bonds started to
form around 13 ns and 17 ns and became stable later on
with the occupancies of 89.6% and 97.7% for Asn343-
Thr885 and Asn343-Gly959, respectively (Figure 9I and
J). The ΔΔG values of the alanine substitution of Asn343
was-4.9 kcal/mol, where the main contribution came
from the loss of van der Waals interactions due to the
increased cavity volume after alanine substitution
(Table 3). The importance of this residue was also
supported by the free energy decomposition per residue
analysis of the 9- and 18-residue with the values of -0.86
and -1.11 kcal/mol, respectively. This Asn343 residue
could play a very important role for a peptide inhibitor
to bind to the EGFR C-lobe interface. However, more
studies may be needed to further confirm the import-
ance of this residue.
Furthermore, the two MIG-6_s1 prolines (Pro339 and
Pro348) and those from EGFR kinase domain (Pro910
and Pro913) could also be essential for the interface
binding. They not only gave the free energy contributions
of about-2.8,-2.2,-4.55 and-3.40 kcal/mol, respectively
(these values were larger than those of the other proline
residues), but their free energy contributions were more
likely to come from the feature of the side-chains that
were-2.34,-2.15,-2.71 and-3.19 kcal/mol more than
those of their backbones, respectively. Moreover, the
proline rings could also form interaction with the side-
chain of Tyr341 and Met346. However, the alanine
scanning technique could not be done because the mu-
tation of proline to alanine causes structural perturba-
tions of the backbone [21-23].
We also performed alanine scanning on the EGFR kin-
ase binding interface, on ten residues, namely, Thr885,
Ile894, Glu904, Glu907, Arg908, Gln911, Tyr920, Val924
Met928 and Ile929. In particular, Thr885 is located within
αF of kinase domain and the side-chain pointed to the
Figure 11 The interactions of the key residues of MIG-6_s1 with nearby residues. (A) The hydrophobic interactions and hydrogen bonds of
Phe352 and nearby residues. (B) The hydrophobic interactions and hydrogen bonds ofTyr358 and nearby residues. (C) The π-π interactions between
the aromatic rings of Phe352 and Tyr358. (D) The hydrogen bond and hydrophobic interactions of Tyr341. (E) The hydrogen bonds between polar
residues of EGFR kinase Glu907 and Thr349 of MIG-6_s1. (F) The hydrogen bonds and hydrophobic interactions of Gln350. (G) The hydrogen bonds of
Asn343 to Thr885 and Gly959. The important interactions were plotted by LIGPLOT program.
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Table 3 The contribution components of binding free energies upon alanine substitutions
Contributions Residue number
Thr885A Tyr891A Ile894A Glu904A Glu907A Arg908A Leu909A Gln911A Tyr920A Val924A
ΔΔEvdw -0.88 -1.22 -1.46 -0.96 -0.67 -4.12 -0.62 -3.12 -2.93 -1.35
ΔΔEelectrostatic -0.99 0.38 0.09 -51.15 -60.00 23.34 0.05 -7.21 0.07 0.08
ΔΔEgas -1.85 -0.83 -1.37 -52.11 -60.66 19.22 -0.57 -10.33 -2.86 -1.27
ΔΔGsol, non pol -0.14 -0.24 -1.20 -1.16 -1.73 -0.78 0.00 -1.30 -1.24 -0.93
ΔΔGsol, PB -0.12 -0.18 -0.31 48.52 57.96 -34.08 -0.03 4.15 0.45 -0.55
ΔΔGsolvation -0.25 -0.42 -1.51 47.36 56.23 -34.86 -0.03 2.85 -0.79 -1.48
ΔΔGsubtotal -2.10 -1.25 -2.88 -4.75 -4.43 -15.65 -0.60 -7.48 -3.65 -2.75
Trp927A Met928A Ile929A Ser337A Leu338A Tyr341A Leu342A Asn343A Met346A Thr349A
ΔΔEvdw -0.70 -3.44 -3.91 -0.43 -3.10 -3.46 -1.40 -4.65 -5.67 -1.10
ΔΔEelectrostatic -0.48 -2.63 -1.37 -0.69 0.11 -6.32 -0.05 -3.06 -1.12 -13.24
ΔΔEgas -1.18 -6.07 -5.28 -1.12 -2.99 -9.78 -1.45 -7.71 -7.10 -14.34
ΔΔGsol, non pol 1.42 -2.22 -1.54 -0.03 -2.54 -1.20 -1.08 -2.19 -3.12 -1.82
ΔΔGsol, PB 0.00 2.99 0.13 1.20 0.73 3.04 0.12 4.98 2.10 8.81
ΔΔGsolvation 1.42 0.77 -1.14 1.17 -1.81 1.84 -0.96 2.80 -1.02 6.99
ΔΔGsubtotal 0.24 -5.30 -6.69 0.05 -4.80 -7.94 -2.41 -4.91 -8.11 -7.35
Contributions Residue number
Gln350A Ser351A Phe352A Asp355A Lys357A Tyr358A Val359A Ser360A Ser361A
ΔΔEvdw -3.82 -0.77 -5.41 -0.18 -2.02 -8.02 -1.56 -1.36 0.15
ΔΔEelectrostatic -6.61 -1.14 0.70 -5.91 1.38 0.14 3.74 -1.52 -8.37
ΔΔEgas -10.43 -1.91 -4.71 -6.10 -0.64 -7.88 2.18 -2.88 -8.22
ΔΔGsol, non pol -1.24 -0.07 -3.39 -0.00 -1.44 -4.57 0.41 -0.20 -0.35
ΔΔGsol, PB 7.34 1.03 -0.46 5.13 0.16 2.50 -3.88 2.98 5.37
ΔΔGsolvation 6.10 0.96 -3.85 5.13 -1.28 -2.07 -4.29 2.77 5.02
ΔΔGsubtotal -4.33 -0.95 -8.56 -0.97 -1.92 -9.95 -2.11 -0.11 -3.02
ΔΔEeJe and ΔΔEvdW are electrostatic and van der Waals contributions in gas phase.
ΔΔGsol,pb and ΔΔGnp are electrostatic and nonpolar contributions in solvation phase.
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(warm spot) as well as forming the hydrophobic pocket
with side-chain of Met346. However, the loss of ΔΔG
(-2.1 kcal/mol) was from the loss of van der Waals and
electrostatic interactions but they were not large effects.
The negatively charged residues of EGFR kinase inter-
face, Glu904 (αG) could form hydrogen bonds with the un-
charged residues of MIG-6_s1, namely Ser360 and Ser361
(warm spot), while the side-chain of Glu907 (at the loop
between αG and -αH) formed hydrogen bond with Thr349
side-chain (hot spot). These Glu904 and Glu907 amino
acids were classified as hot spot residues due to the muta-
tion of two glutamic acids resulting with the ΔΔG costs
of-4.75 and-4.43 kcal/mol, respectively. The loss of electro-
static contribution was the major reason of such results.
Likewise, the positively charged Arg908 located between
αG and αH possibly made strong hydrogen bonds with
the backbone of Gln350 (hot spot) and the side-chain of
Tyr358 (hot spot). After alanine mutation, Arg908 wasidentified as a hot spot residue because of its ΔΔG-
15.65 kcal/mol that may have been influenced by the
increasing cavity volume and the disrupting the conven-
tional hydrogen bonds upon mutating the side-chain.
Moreover, the “nitrogen-containing” side chains of Arg908
lining in parallel with the aromatic ring of Tyr358 also
formed the cation-π interaction. Although this geometry
layout is preferred in protein structures, the mutation of
the side-chain could render large favorable electrostatic
contribution in the polar solvation [35].
Gln911 (on the loop between αG-αH) was also indi-
cated as a hot spot residue. It disrupted strong hydrogen
bonds to Ser337 side-chain upon alanine substitution
causing the binding free energy-7.48 kcal/mol, but did
not disturb a hydrogen bond of the backbone-side chain
between Gln911 and Tyr341. The alignment on αH of
Tyr920, Val924 and Met928 showed that they are im-
portant to the dimer formation, which were called as
“The core of the asymmetric EGFR kinase domain” [36].
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phobic interactions that involve residues in the N-lobe
of EGFR kinase receiver, but their mutations also abro-
gated the contribution of the asymmetric dimer [6,36].
These experimental results align with our in silico pre-
dictions, these residues were superimposed to those in dif-
ferent structures as shown in the RMSF plots (Figure 3)
demonstrating the stability of their backbones. Moreover,
we took the EGFR kinase activator interface when binding
to MIG-6_s1 and compared with the one when binding to
the EGFR kinase receiver. The important of these residues
were observed on the above EGFR kinase activator inter-
faces. After alanine mutations, the loss of van der Waals
interaction could originate from the disruption of hydro-
phobic interaction to their partner proteins. The binding
energies of Tyr920, Val924 and Met928 values are-3.65,-
2.75, and-5.30 kcal/mol (when binding to MIG-6_s1) and-
3.46,-4.98, and-6.07 kcal/mol (when binding to receiver
kinase), respectively. The sharing residues between two
interfaces of the activator entail that MIG-6_s1 might bind
the EGFR kinase activator in the manner similar to a bind-
ing of the receiver kinase, even though the function of
MIG-6_s1 was opposed to the receiver kinase [6,37].
Conclusions
In this study, the 22 ns MD simulations of EGFR kinase/
MIG-6_s1 complex was performed in order to provide
more understanding about the binding of MIG-6_s1
peptide to the C-lobe of EGFR kinase that is an import-
ant target in cancer therapy. Using both per residue
free energy decomposition and computational alanine
scanning techniques, we found that the Asn343 residue
situates on a flexible loop of MIG-6_s1. This particular
loop was absent in the original X-ray crystal structure.
Furthermore, the underlying loop potentially renders
Asn343 a key residue to bind to EGFR kinase. This
finding requires further experimental validation to better
our understanding about Asn343 role in the protein-
protein interaction.
In addition, we used the above energy calculation tech-
niques to identify the hot spot residues (six residues on
EGFR kinase and eight residues on MIG-6_s1) that play
significant role in the binding between the two proteins.
Particularly, the alanine scanning technique showed that
the alanine mutations on these hot spot residues would
worsen the EGFR kinase/MIG-6_s1 interaction. This
technique also revealed the other important residues but
to a lesser extent, called warm spot residues that might
be worth to further investigate their binding roles. These
key amino acids proposed in this work should play vital
role for a peptide-based inhibitor to prevent the EGFR
asymmetric dimer formation. This in silico study,
hence, provides valuable information for designing new
peptide-based cancer drugs.Abbreviations
EGFR: Epidermal growth factor receptor; MIG-6_s1: Mitogen induce gene 6
segment1; MM-PBSA: Molecular mechanics/poisson-boltzmann surface area;
RMSD: Root-mean-square-deviations.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
NM carried out the molecular dynamic simulations, performed the analysis
and drafted the manuscript. NS, SR, WM and SC participated in molecular
dynamic simulations and provided technical advice. ST and KC conceived
the initial concept of the study, and participated in its design and
coordination of drafting the manuscript. All authors read and approved the
final manuscript.
Acknowledgements
This work was supported by National Science and Technology Development
Agency (NSTDA) under the Thailand Graduate Institute of Science and
Technology (TGIST) programme. The scholar student ID is TG-22-11-55-024 M
and the grant number is TGIST 01–55–024. ST acknowledges Cluster and
Program Management Office (CPMO), National Science and Technology
Development Agency (NSTDA), grant no. P-10-10567 for partially supporting
this work. KC is supported by Faculty of Science, Kasetsart University, and
Thailand Research Fund (RSA5780066). SC is supported by Grants for
Development of New Faculty Staff, Ratchadaphiseksomphot Endowment
Fund, Chulalongkorn University. The authors would like to thankand the
National Center for Genetic Engineering and Biotechnology (BIOTEC) and the
National Science and Technology Development Agency (NSTDA) for the use
of high performance computer clusters.
Author details
1Department of Biochemistry, Faculty of Science, Kasetsart University, 50
Ngam, Wong Wan Rd, Bangkok, Chatuchak 10900, Thailand. 2Center of Data
Mining and Biomedical Informatics, Faculty of Medical Technology, Mahidol
University, Bangkok 10700, Thailand. 3Department of Biochemistry, Faculty of
Science, Chulalongkorn University, Bangkok, Pathum Wan 10330, Thailand.
4Genetic Engineering Interdisciplinary Program, Graduate School, Kasetsart
University, 50 Ngam Wong Wan Rd, Bangkok, Chatuchak 10900, Thailand.
5Genome Technology Research Unit, National Center for Genetic Engineering
and Biotechnology, National Science and Technology Development Agency
(NSTDA), 113 Thailand Science Park, Phahonyothin Road, Khlong Nueng,
Pathum Thani, Khlong Luang 12120, Thailand. 6Center for Advanced Studies
in Tropical Natural Resources, National Research, University-Kasetsart
University, Kasetsart University, Bangkok, Chatuchak 10900, Thailand.
Received: 8 September 2014 Accepted: 6 March 2015
References
1. Hynes NE, MacDonald G. ErbB receptors and signaling pathways in cancer.
Curr Opin Cell Biol. 2009;21(2):177–84.
2. Sebastian S, Settleman J, Reshkin SJ, Azzariti A, Bellizzi A, Paradiso A. The
complexity of targeting EGFR signalling in cancer: from expression to
turnover. Biochim Biophys Acta. 2006;1766(1):120–39.
3. Wang DD, Zhou W, Yan H, Wong M, Lee V. Personalized prediction of EGFR
mutation-induced drug resistance in lung cancer. Sci Rep. 2013;3:2855.
4. Friedman R. Drug resistance missense mutations in cancer are subject to
evolutionary constraints. PLoS One. 2013;8(12):e82059.
5. Yun CH, Mengwasser KE, Toms AV, Woo MS, Greulich H, Wong KK. The
T790M mutation in EGFR kinase causes drug resistance by increasing the
affinity for ATP. Proc Natl Acad Sci U S A. 2008;105(6):2070–5.
6. Zhang X, Pickin KA, Bose R, Jura N, Cole PA, Kuriyan J. Inhibition of the EGF
receptor by binding of MIG6 to an activating kinase domain interface.
Nature. 2007;450(7170):741–4.
7. Zhang YW, Vande Woude GF. Mig-6, signal transduction, stress response
and cancer. Cell Cycle. 2007;6(5):507–13.
8. Zhang YW, Staal B, Su Y, Swiatek P, Zhao P, Cao B, et al. Evidence that
MIG-6 is a tumor-suppressor gene. Oncogene. 2007;26(2):269–76.
Moonrin et al. BMC Bioinformatics  (2015) 16:103 Page 16 of 169. Yang Y, Liu H, Yao X. Understanding the molecular basis of MK2-p38alpha
signaling complex assembly: insights into protein-protein interaction by
molecular dynamics and free energy studies. Mol BioSyst. 2012;8(8):2106–18.
10. Guo J, Wang X, Sun H, Liu H, Yao X. The molecular basis of IGF-II/IGF2R
recognition: a combined molecular dynamics simulation, free-energy
calculation and computational alanine scanning study. J Mol Model.
2012;18(4):1421–30.
11. Case DA, Cheatham 3rd TE, Darden T, Gohlke H, Luo R, Merz Jr KM, et al.
The Amber biomolecular simulation programs. J Comput Chem. 2005;26
(16):1668–88.
12. Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML. Comparison
of simple potential functions for simulating liquid water. J Chem Physics.
1983;79(2):926–35.
13. Darden T, York D, Pedersen L. Particle mesh Ewald: an n⋅log (N) method for
Ewald sums in large systems. J Chem Physics. 1993;98(12):10089–92.
14. Miyamoto S, Kollman PA. Settle: an analytical version of the SHAKE and
RATTLE algorithm for rigid water models. J Comput Chem. 1992;13(8):952–62.
15. Kollman PA, Massova I, Reyes C, Kuhn B, Huo S, Chong L, et al. Calculating
structures and free energies of complex molecules: combining molecular
mechanics and continuum models. Acc Chem Res. 2000;33(12):889–97.
16. Weiser J, Shenkin PS, Still WC. Approximate atomic surfaces from
linear combinations of pairwise overlaps (LCPO). J Comput Chem.
1999;20(2):217–30.
17. Zhong H, Carlson HA. Computational studies and peptidomimetic design
for the human p53-MDM2 complex. Proteins. 2005;58(1):222–34.
18. Li T, Froeyen M, Herdewijn P. Computational alanine scanning and free
energy decomposition for E. coli type I signal peptidase with lipopeptide
inhibitor complex. J Mol Graph Model. 2008;26(5):813–23.
19. Bradshaw RT, Patel BH, Tate EW, Leatherbarrow RJ, Gould IR. Comparing
experimental and computational alanine scanning techniques for
probing a prototypical protein-protein interaction. Protein Eng Des Sel.
2011;24(1–2):197–207.
20. Saiz-Urra L, Cabrera MA, Froeyen M. Exploring the conformational changes
of the ATP binding site of gyrase B from Escherichia coli complexed with
different established inhibitors by using molecular dynamics simulation:
protein-ligand interactions in the light of the alanine scanning and free
energy decomposition methods. J Mol Graph Model. 2011;29(5):726–39.
21. Morrison KL, Weiss GA. Combinatorial alanine-scanning. Curr Opin Chem
Biol. 2001;5(3):302–7.
22. Bullock BN, Jochim AL, Arora PS. Assessing helical protein interfaces for
inhibitor design. J Am Chem Soc. 2011;133(36):14220–3.
23. Massova I, Kollman PA. Computational alanine scanning to probe protein −
protein interactions: a novel approach to evaluate binding free energies.
J Am Chem Soc. 1999;121(36):8133–43.
24. Sousa SF, Tamames B, Fernandes PA, Ramos MJ. Detailed atomistic analysis
of the HIV-1 protease interface. J Phys Chem B. 2011;115(21):7045–57.
25. Espinoza-Fonseca LM, Trujillo-Ferrara JG. Conformational changes of the
p53-binding cleft of MDM2 revealed by molecular dynamics simulations.
Biopolymers. 2006;83(4):365–73.
26. Red Brewer M, Choi SH, Alvarado D, Moravcevic K, Pozzi A, Lemmon MA,
et al. The juxtamembrane region of the EGF receptor functions as an
activation domain. Mol Cell. 2009;34(6):641–51.
27. Bonvin AM, Brunger AT. Conformational variability of solution nuclear
magnetic resonance structures. J Mol Biol. 1995;250(1):80–93.
28. Wallace AC, Laskowski RA, Thornton JM. LIGPLOT: a program to generate
schematic diagrams of protein-ligand interactions. Protein Eng. 1995;8
(2):127–34.
29. McGaughey GB, Gagne M, Rappe AK. pi-Stacking interactions: alive and well
in proteins. J Biol Chem. 1998;273(25):15458–63.
30. Stein A, Aloy P. Contextual specificity in peptide-mediated protein interactions.
PLoS One. 2008;3(7):e2524.
31. Niu RJ, Zheng QC, Zhang JL, Zhang HX. Molecular dynamics simulations
studies and free energy analysis on inhibitors of MDM2-p53 interaction.
J Mol Graph Model. 2013;46:132–9.
32. Huo S, Massova I, Kollman PA. Computational alanine scanning of the 1:1
human growth hormone-receptor complex. J Comput Chem. 2002;23(1):15–27.
33. Moreira IS, Fernandes PA, Ramos MJ. Hot spots–a review of the protein-protein
interface determinant amino-acid residues. Proteins. 2007;68(4):803–12.
34. Pons J, Rajpal A, Kirsch JF. Energetic analysis of an antigen/antibody
interface: alanine scanning mutagenesis and double mutant cycles on the
HyHEL-10/lysozyme interaction. Protein Sci. 1999;8(5):958–68.35. Crowley PB, Golovin A. Cation-pi interactions in protein-protein interfaces.
Proteins. 2005;59(2):231–9.
36. Zhang X, Gureasko J, Shen K, Cole PA, Kuriyan J. An allosteric mechanism
for activation of the kinase domain of epidermal growth factor receptor.
Cell. 2006;125(6):1137–49.
37. Jura N, Endres NF, Engel K, Deindl S, Das R, Lamers MH, et al. Mechanism
for activation of the EGF receptor catalytic domain by the juxtamembrane
segment. Cell. 2009;137(7):1293–307.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
